LncRNA NEAT1 Promotes the Progression of Gastric Cancer Through Modifying the miR-1224-5p/RSF1 Signaling Axis

Luoluo Yang1, Min Wang2, Ping He1

  • 1Department of Gastroenterology, First Hospital of Jilin University, Changchun 130021, Jilin, People's Republic of China.

Abstract

Insights

Nuclear paraspeckle assembly transcript 1 (NEAT1) promotes gastric cancer progression by sponging miR-1224-5p, leading to increased remodeling and spacing factor 1 (RSF1) expression. This finding offers new avenues for gastric cancer diagnosis and therapy.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Cancer Biology

Background:

  • Advanced gastric cancer presents significant therapeutic challenges.
  • Long non-coding RNAs (lncRNAs) are implicated in gastric cancer, but specific roles like NEAT1 remain underexplored.

Purpose of the Study:

  • To investigate the functional role and molecular mechanism of NEAT1 in gastric cancer.
  • To elucidate the regulatory relationship between NEAT1, miR-1224-5p, and RSF1 in gastric cancer progression.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC) to assess NEAT1, miR-1224-5p, and RSF1 expression.
  • Bioinformatics analysis (ENCORI) for predicting binding sites.
  • Cell proliferation (CCK-8), migration (wound healing, Transwell), and interaction (luciferase) assays to validate molecular mechanisms.

Main Results:

  • NEAT1 and RSF1 were highly expressed, while miR-1224-5p was decreased in gastric cancer tissues.
  • NEAT1 upregulation enhanced gastric cancer cell proliferation and migration.
  • NEAT1 acts as a molecular sponge for miR-1224-5p, inhibiting its binding to RSF1 and promoting cancer cell malignancy.

Conclusions:

  • NEAT1 regulates RSF1 expression via competitive sponging of miR-1224-5p.
  • This regulatory axis contributes to gastric cancer progression.
  • Findings provide novel insights for gastric cancer diagnosis and therapeutic strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K